Motor Matters: Tackling Heterogeneity of Parkinson's Disease in Functional MRI Studies

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Holiga, Štefan ^a   Mueller, Karsten ^a   Möller, Harald E ^a   Sieger, Tomáš ^b,c   Schroeter, Matthias L ^a,d   Vymazal, Josef ^e   Růžička, Evžen ^b   Jech, Robert ^b  

^a MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

ADULT; ARTICLE; BASAL GANGLION; BRAIN REGION; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; SCORING SYSTEM; SYMPTOMATOLOGY; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIPARKINSON AGENTS; BASAL GANGLIA; CARBIDOPA; DISABILITY EVALUATION; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84873904253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056133     Document Type: Article

References (42)

1. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, et al. (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40: 1529-1534.
2. Albin RL, Dauer WT, (2012) Parkinson syndrome: Heterogeneity of etiology; heterogeneity of pathogenesis? Neurology 79: 202-203.
3. Hughes AJ, Daniel SE, Kilford L, Lees AJ, (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
4. Schiess MC, Zheng H, Soukup VM, Bonnen JG, Nauta HJ, (2000) Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. Parkinsonism Relat Disord 6: 69-76.
5. Fahn S, Elton R, Members of the UPDRS Development Committee (1987) In:Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information. 153-163, 293-304.
6. Movement Disorder Society Task Force on Rating Scales for Parkinson's D (2003) The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18: 738-750.
7. Ashburner J, Friston KJ, (2005) Unified segmentation. Neuroimage 26: 839-851.
8. Friston KJ, Fletcher P, Josephs O, Holmes A, Rugg MD, et al. (1998) Event-related fMRI: characterizing differential responses. Neuroimage 7: 30-40.
9. Josephs O, Henson RN, (1999) Event-related functional magnetic resonance imaging: modelling, inference and optimization. Philos Trans R Soc Lond B Biol Sci 354: 1215-1228.
10. Friston K, Holmes AP, Worsley KJ, Poline JB, (1995) Statistical Parametric Maps in Functional Imaging: A General Linear Approach. Hum Brain Mapp 2: 189-210.
11. Holiga Š, Möller HE, Sieger T, Schroeter ML, Jech R, et al. (2012) Accounting for movement increases sensitivity in detecting brain activity in Parkinson's disease. PLoS One 7: e36271.
12. Kraft E, Loichinger W, Diepers M, Lule D, Schwarz J, et al. (2009) Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study. Parkinsonism Relat Disord 15: 558-563.
13. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, et al. (2001) Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57: 2083-2088.
14. Mallol R, Barros-Loscertales A, Lopez M, Belloch V, Parcet MA, et al. (2007) Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Res 1147: 265-271.
15. Prodoehl J, Spraker M, Corcos D, Comella C, Vaillancourt D, (2010) Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease. Mov Disord 25: 2035-2043.
16. Wu T, Wang L, Hallett M, Li K, Chan P, (2010) Neural correlates of bimanual anti-phase and in-phase movements in Parkinson's disease. Brain 133: 2394-2409.
17. Wu T, Wang L, Hallett M, Chen Y, Li K, et al. (2011) Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. Neuroimage 55: 204-215.
18. Jech R, Mueller K, Urgosik D, Sieger T, Holiga S, et al. (2012) The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in FMRI. PLoS One 7: e49056.
19. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, et al. (2000) Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 123 (Pt 2): 394-403.
20. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, et al. (2001) Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124: 558-570.
21. Wu T, Hallett M, (2005) A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 128: 2250-2259.
22. Macri MA, Garreffa G, Giove F, Moraschi M, Giulietti G, et al. (2006) A cluster-based quantitative procedure in an fMRI study of Parkinson's disease. Magn Reson Imaging 24: 419-424.
23. Holden A, Wilman A, Wieler M, Martin WR, (2006) Basal ganglia activation in Parkinson's disease. Parkinsonism Relat Disord 12: 73-77.
24. Wu T, Hallett M, (2008) Neural correlates of dual task performance in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 79: 760-766.
25. Palmer SJ, Eigenraam L, Hoque T, McCaig RG, Troiano A, et al. (2009) Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease. Neuroscience 158: 693-704.
26. Palmer SJ, Ng B, Abugharbieh R, Eigenraam L, McKeown MJ, (2009) Motor reserve and novel area recruitment: amplitude and spatial characteristics of compensation in Parkinson's disease. Eur J Neurosci 29: 2187-2196.
27. Moraschi M, Giulietti G, Giove F, Guardati M, Garreffa G, et al. (2010) fMRI study of motor cortex activity modulation in early Parkinson's disease. Magn Reson Imaging 28: 1152-1158.
28. Palmer SJ, Li J, Wang ZJ, McKeown MJ, (2010) Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease. Neuroscience 166: 1110-1118.
29. Sen S, Kawaguchi A, Truong Y, Lewis MM, Huang X, (2010) Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease. Neuroscience 166: 712-719.
30. Ng B, Palmer S, Abugharbieh R, McKeown MJ, (2010) Focusing effects of L-dopa in Parkinson's disease. Hum Brain Mapp 31: 88-97.
31. Spraker MB, Prodoehl J, Corcos DM, Comella CL, Vaillancourt DE, (2010) Basal ganglia hypoactivity during grip force in drug naive Parkinson's disease. Hum Brain Mapp 31: 1928-1941.
32. Kalmar Z, Kovacs N, Perlaki G, Nagy F, Aschermann Z, et al. (2011) Reorganization of motor system in Parkinson's disease. Eur Neurol 66: 220-226.
33. Pinto S, Mancini L, Jahanshahi M, Thornton JS, Tripoliti E, et al. (2011) Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson's disease. Mov Disord 26: 2212-2219.
34. Gonzalez-Garcia N, Armony JL, Soto J, Trejo D, Alegria MA, et al. (2011) Effects of rTMS on Parkinson's disease: a longitudinal fMRI study. J Neurol 258: 1268-1280.
35. Martinu K, Degroot C, Madjar C, Strafella AP, Monchi O, (2012) Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease. Eur J Neurosci 35: 572-583.
36. Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, et al. (1996) Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Neurology 46: 1430-1436.
37. Foltynie T, Brayne C, Barker RA, (2002) The heterogeneity of idiopathic Parkinson's disease. J Neurol 249: 138-145.
38. Buhmann C, Glauche V, Sturenburg HJ, Oechsner M, Weiller C, et al. (2003) Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126: 451-461.
39. Tessa C, Lucetti C, Diciotti S, Baldacci F, Paoli L, et al. (2010) Decreased and increased cortical activation coexist in de novo Parkinson's disease. Exp Neurol 224: 299-306.
40. Helmich RC, Bloem BR, Toni I (2011) Motor imagery evokes increased somatosensory activity in parkinson's disease patients with tremor. Hum Brain Mapp.
41. Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, et al. (2012) Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task. Mov Disord 27: 364-371.
42. Tessa C, Lucetti C, Diciotti S, Paoli L, Cecchi P, et al. (2012) Hypoactivation of the primary sensorimotor cortex in de novo Parkinson's disease: a motor fMRI study under controlled conditions. Neuroradiology 54: 261-268.